Tony Edwards, author of «The good news about booze» and University College
London Pharmacologist, Professor David Colquhoun, will debate «Is drinking good for your health?»
Not exact matches
«Resolvin D2 is an excellent prototype for a new anti-inflammatory drug,» says
pharmacologist Mauro Perretti of Queen Mary University of
London, one of the study's authors.
Vallance, a clinical
pharmacologist who previously led the medical division at University College
London, will replace Mark Walport in April 2018.
«They are the most rigorous double - blind placebo - controlled trials of a psychedelic drug in the past 50 years,» writes David Nutt, a
pharmacologist at Imperial College
London who was not involved in the work, in an editorial accompanying the papers.
See a short analysis by
pharmacologist David Colquhoun of University College
London here http://www.theguardian.com/science/2011/sep/05/publish-perish-peer-review-science.